This bill establishes THC potency limits for various cannabis products, including cannabis flower, concentrates, and topical or transdermal products, while also mandating warning notices at retail locations and on product labels. Specifically, it sets a maximum of 15% total THC for cannabis flower, 30% for cannabis concentrates, and 500 milligrams per package for topical or transdermal products. Additionally, the bill prohibits the sale of cannabis flower or prerolls infused with additional THC or psychoactive cannabinoids. It also outlines specific labeling requirements for cannabis products, including detailed information about the product's origin, cannabinoid profile, and various health warnings.

The bill amends several sections of Minnesota Statutes, adding new definitions and subdivisions related to cannabis products and their regulation. It requires cannabis businesses to post warning notices at retail locations, including statements about the risks associated with cannabis use, particularly for individuals under 25 and for pregnant or breastfeeding women. The labeling requirements are extensive, ensuring that consumers are informed about the potential risks of cannabis products, including the possibility of cannabis poisoning in children and the effects of THC on mental health and development.

Statutes affected:
Introduction: 342.01, 342.06, 342.27